AmethIntel™

Bring the data to the deal table.

Every deal rests on assumptions.Ground yours in data.

AmethIntel tests them against the trials, the patents and the competition, in 48 hours.

Confidence. Better terms. The right decision.

See the example dashboard Preparing for Series A? Start with Steer
  • For founders, BD teams and investors
  • Biotech, pharma, healthtech, deep tech
Deal terms Valuation ASSUMPTIONS TRIALS PATENTS COMPETITION ADJACENT SCIENCE ROUTE TO MARKET GROUNDED IN DATA B-01 · STRUCTURE: YOUR DEAL B-02 · FOUNDATION: AMETHINTEL AMETHINTEL DEAL FOUNDATION DWG 02 REV A

Evaluating a target or a market?

AmethIntel Reports

Target-level intelligence for BD teams, diagnostics developers and investors. The first report covers CEACAM5: 187 registered trials mapped, 44 treatments analysed, 1,000+ patents screened.

See the reports Read the CEACAM5 case study

One board. Delivered in 48 hours.

Every finding traces to a patent, a registered trial or a peer-reviewed paper. The references and the raw data are yours.

  • Clinical trialsEnrichment, inclusion and exclusion criteria, endpoints, adverse events.
  • PatentsWhere the barriers are real and where they are permeable. Not a formal FTO opinion.
  • CompetitionWho is where, and where the space is still open.
  • Adjacent scienceThreats and openings from neighbouring fields and academic IP.
  • Route to marketRegulatory path, prescribers and payers.

This is what a client receives, shown for CEACAM5 with the interpretation locked.

Open the example dashboard

Also from AmethIntel

  • Prag

    Writing help for business plans, grants and papers, built on the same sourced data.

  • Takes Two

    Takes Two to Tango: strategies to increase the value of an asset by pooling fragmented datasets.

  • AmethOnc Updates

    Our monthly oncology newsletter.